Results 61 to 70 of about 18,464 (76)

Drug resistance mutations to integrase inhibitors, proteinase, and reverse transcriptase inhibitors in newly diagnosed HIV-1 infections in Hebei province, China, 2018-2022. [PDF]

Front Cell Infect Microbiol
Lu X, Li Y, Liu M, Wang Y, An N, Sun D, Li Q.   +6 more
europepmc   +1 more source

Resistance to Dolutegravir in Treatment-experienced Patients in South Africa: A Retrospective Cohort Study. [PDF]

J Acquir Immune Defic Syndr
Zhao Y, Holtman M, Mudaly V, van Zyl G, Maartens G, Meintjes G.   +5 more
europepmc   +1 more source

Pretreatment HIV Drug Resistance to Integrase Strand Transfer Inhibitors Among Newly Diagnosed HIV Individuals - China, 2018-2023. [PDF]

China CDC Wkly
Hu H, Hao J, Wang D, Liu X, Chen H, Li F, Chen J, Li M, Xin P, Li Y, Li Q, Li H, Li J, Hu J, Song C, Feng Y, Liao L, Ruan Y, Xing H.   +18 more
europepmc   +1 more source

Development and validation of optimized lentivirus-like particles for gene editing tool delivery with Gag-Only strategy. [PDF]

Eur J Med Res
Jia J, Hao Y, Zhang L, Cao X, An L, Wang H, Ma Q, Jin X, Ma X.   +8 more
europepmc   +1 more source

High prevalence of reverse transcriptase inhibitors associated resistance mutations among people living with HIV on dolutegravir-based antiretroviral therapy in Francistown, Botswana. [PDF]

J Antimicrob Chemother
Choga OT, Lemogang GM, Choga WT, Muzanywa G, Shadreck TM, Ralegoreng C, Maruapula D, Moraka NO, Koofhethile CK, Mokgethi PT, Seru K, Zuze BJL, Montshosi P, Gobe I, Motswaledi MS, Musonda R, Mbulawa MB, Makhema J, Shapiro R, Lockman S, Chebani T, Nawa J, Bochena L, Moyo S, Gaseitsiwe S.   +24 more
europepmc   +1 more source

Comparative Analyses of Antiviral Potencies of Second-Generation Integrase Strand Transfer Inhibitors (INSTIs) and the Developmental Compound 4d Against a Panel of Integrase Quadruple Mutants. [PDF]

Viruses
Smith SJ, Zhao XZ, Hughes SH, Burke TR.
europepmc   +1 more source

DEFINE: A Prospective, Randomized, Phase 4 Trial to Assess a Protease Inhibitor-Based Regimen Switch Strategy to Manage Integrase Inhibitor-Related Weight Gain. [PDF]

Clin Infect Dis
Anderson D, Ramgopal M, Hagins DP, Lee J, Simonson RB, Hsu TH, Xu P, Ahmad N, Short WR.   +8 more
europepmc   +1 more source

Drug Resistance Mutations (DRMs) for Long-Acting Injectable Cabotegravir and Rilpivirine (CAB/RPV LAI) in the HIV-1 Subtype A6 Epidemic in Poland. [PDF]

Microorganisms
Załęski A, Lembas A, Dyda T, Osińska J, Jabłońska J, Stempkowska-Rejek J, Orzechowska J, Wiercińska-Drapało A.   +7 more
europepmc   +1 more source

Viral suppression in the context of SARS-CoV-2 among children infected with HIV-1 monitored in five health facilities in Benin. [PDF]

BMC Infect Dis
Dagba Gbessin EH, Gomgnimbou MK, Keke RK, Sina H, Afangnihoun A, Bachabi M, Ouedraogo AS, Baba-Moussa L.   +7 more
europepmc   +1 more source

Changes in Hepatic Steatosis Before and After Direct-Acting Antiviral Treatment in People With HIV and Hepatitis C Coinfection. [PDF]

J Infect Dis
Truscello E, Wang S, Young J, Sebastiani G, Walmsley SL, Hull M, Cooper C, Klein MB.   +7 more
europepmc   +1 more source